-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KsPxVpj1TutnTxjvDcy6ikSt1j5msV1+fFrRdlZVGSixGugg/3AwurN0zCsXaJtw M5FUfyV+esyHLr9RTKjsYg== 0000875320-09-000036.txt : 20090528 0000875320-09-000036.hdr.sgml : 20090528 20090528161536 ACCESSION NUMBER: 0000875320-09-000036 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090526 FILED AS OF DATE: 20090528 DATE AS OF CHANGE: 20090528 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 09857688 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2009-05-26 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139 1 0 0 0 Common Stock 2009-05-26 4 S 0 2100 28.75 D 1118095 D Common Stock 2009-05-26 4 S 0 24800 29.49 D 1093295 D Common Stock 2009-05-27 4 S 0 26900 29.44 D 1066395 D Common Stock 13286 I 401(k) Common Stock 207500 I Shares in trust. Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $28.75 (range $28.17 to $29.16). Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $29.49 (range $29.23 to $29.74). Open market sales reported on this line occurred at a weighted average price of $29.44 (range $29.09 to $29.89). Shares held in trust for Dr. Boger's children. Dr. Boger disclaims beneficial ownership of such shares. Valerie L. Andrews, Attorney-In-fact 2009-05-28 -----END PRIVACY-ENHANCED MESSAGE-----